Abstract
Novel solid forms of an anti-inflammatory drug, oxaprozin, were identified. A drug–drug salt of oxaprozin with salbutamol was proved promising for development of extended release tablet formulations of salbutamol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have